Surrogacy of intermediate endpoints for overall survival in randomized controlled trials of first-line treatment for advanced soft tissue sarcoma in the pre- and post-pazopanib era: a meta-analytic evaluation.
Surrogacy of intermediate endpoints for overall survival in randomized controlled trials of first-line treatment for advanced soft tissue sarcoma in the pre- and post-pazopanib era: a meta-analytic evaluation.
复制标题
帕唑帕尼时代前后晚期软组织肉瘤一线治疗的随机对照试验中总生存期的中间终点替代：荟萃分析评估。
DOI：
10.1186/s12885-019-5268-2
复制
发表时间：
2019
期刊：
影响因子：
--
通讯作者：
Tsumura H.
中科院分区：
文献类型：
--
作者：
Tanaka K;Kawano M;Iwasaki T;Itonaga I;Tsumura H.
